Associate Director, Experimental Process Development PC 1519

Miltenyi Biotec•Gaithersburg, MD

About The Position

Your Role: Miltenyi Biotec is seeking a visionary and strategic Associate Director of Experimental Process Development to spearhead the establishment of a robust lipid nanoparticle (LNP) platform for therapeutic delivery, while continuing to advance our lentiviral vector (LVV) pipeline. This role places LNP innovation at the core of our next-generation delivery strategy, driving the development of scalable, high-quality manufacturing processes for both viral and non-viral modalities. As the Associate Director, you will lead a team of five scientists and work in close collaboration with the broader Miltenyi Bioindustry Process Development organization. The ideal candidate will bring deep technical expertise in nanoparticle and/or viral vector technologies, strong strategic vision, and a collaborative mindset to expand platform capabilities and accelerate translation into impactful therapeutic solutions. Essential Duties and Responsibilities: Lead and mentor a team of scientists in the design and optimization of lipid nanoparticle (LNP) platforms, while advancing upstream and downstream processes for viral vectors including lentivirus and AAV. Drive scientific and technological innovation to improve LNP formulation, encapsulation efficiency, stability, scalability, and to enhance viral vector productivity, purity, and robustness. Develop and execute strategic process-development plans that accelerate LNP platform maturation and support integrated viral vector development in alignment with organizational objectives. Partner cross-functionally with Analytical Development, Manufacturing, Quality, and other Bioindustry teams to ensure seamless integration of LNP and viral vector workflows. Evaluate emerging technologies in nanoparticle engineering, nucleic acid delivery, and viral vector production, and incorporate high-impact approaches into development pipelines. Ensure compliance with regulatory, quality, and safety standards across all LNP and viral vector R&D activities. Present scientific findings, program updates, and strategic recommendations to senior leadership and external collaborators. Foster a culture of scientific excellence, innovation, and continuous improvement within the platform development organization.

Requirements

Ph.D. or master’s degree in Biochemical Engineering, Molecular Biology, or related field and 10+ years of experience in bioprocess development, with a focus on viral vectors and/or LNPs.
Proven leadership experience managing scientific teams and cross-functional projects.
Strong understanding of GMP principles, tech transfer, and regulatory expectations.
Demonstrated ability to translate scientific innovation into scalable processes.
Excellent communication, strategic thinking, and problem-solving skills.
Ability to generate and implement new ideas that push the boundaries of current technologies.
Capable of setting long-term vision and aligning team efforts with business objectives.
Skilled in building partnerships across departments and sites.
Balance creativity with operational discipline to deliver results.

Responsibilities

Lead and mentor a team of scientists in the design and optimization of lipid nanoparticle (LNP) platforms, while advancing upstream and downstream processes for viral vectors including lentivirus and AAV.
Drive scientific and technological innovation to improve LNP formulation, encapsulation efficiency, stability, scalability, and to enhance viral vector productivity, purity, and robustness.
Develop and execute strategic process-development plans that accelerate LNP platform maturation and support integrated viral vector development in alignment with organizational objectives.
Partner cross-functionally with Analytical Development, Manufacturing, Quality, and other Bioindustry teams to ensure seamless integration of LNP and viral vector workflows.
Evaluate emerging technologies in nanoparticle engineering, nucleic acid delivery, and viral vector production, and incorporate high-impact approaches into development pipelines.
Ensure compliance with regulatory, quality, and safety standards across all LNP and viral vector R&D activities.
Present scientific findings, program updates, and strategic recommendations to senior leadership and external collaborators.
Foster a culture of scientific excellence, innovation, and continuous improvement within the platform development organization.